ClinConnect ClinConnect Logo
Search / Trial NCT03432702

Horizontal Ridge Augmentation With or Without Autogenous Block Grafts

Launched by UNIVERSIDAD CIENTÍFICA DEL SUR · Feb 7, 2018

Trial Information

Current as of May 27, 2025

Completed

Keywords

ClinConnect Summary

Forty-two patients with 42 severe horizontal bone atrophy sites in the maxilla or mandible will be randomly assigned to two groups: ABG or GBR.

In the ABG group, a combination of ABG with particulate xenograft, covered with collagen membrane, will be used, while only a combination of particulate xenograft and collagen membrane alone will be in the GBR group. After 6-9 months of healing, implants were inserted. All implants will be definitively restored 6 months after implant placement. Radiographic examination (cone beam computed tomograms, CBCT) will be performed to evaluate the amount of...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years old, who required an implant supported restoration in at least one site, with severe atrophy of the alveolar ridge in the horizontal plane (class III-IV atrophy according to Cawood and Howell classification),
  • adequate oral hygiene
  • no history of previous bone augmentation procedures at the implant site, and
  • able to understand and sign an informed consent form.
  • Exclusion Criteria:
  • uncontrolled systemic conditions, irradiation in the head and neck area, - immunosuppressed or immunocompromised,
  • presented with oral disorders (such as lichen planus),
  • treated or under treatment with intravenous amino-bisphosphonates,
  • untreated periodontitis, poor oral hygiene and motivation,
  • parafunctional habits,
  • pregnant or lactating,
  • drug or alcohol abuse,
  • psychiatric disorders,
  • a history (within the last 3 months) of using (at least weekly or more frequently) smokeless chewing tobacco, smoking a pipe, cigar or cigarette (at a rate of more than 10 cigarettes per day),
  • acute/chronic infection/inflammation in the area, or
  • an extraction with less than 3 months of healing

About Universidad Científica Del Sur

Universidad Científica del Sur is a renowned academic institution dedicated to advancing scientific research and innovation in the fields of health and environmental sciences. As a clinical trial sponsor, the university leverages its extensive expertise and resources to facilitate groundbreaking studies aimed at improving patient care and outcomes. Committed to ethical practices and rigorous methodologies, Universidad Científica del Sur collaborates with healthcare professionals and researchers to address pressing medical challenges, contributing to the global body of knowledge and enhancing public health initiatives.

Locations

Lima, , Peru

Patients applied

0 patients applied

Trial Officials

Gerardo Mendoza-Azpur, DDS

Principal Investigator

Científica del Sur University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials